Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Jul;85(2):176–181. doi: 10.1054/bjoc.2001.1880

A novel deletion mutation of the EXT2 gene in a large Chinese pedigree with hereditary multiple exostosis

C Y Xiao 1,2, J Wang 1,2, S Z Zhang 1,2, W Van Hul 3, W Wuyts 3, W M Qiu 1,2, H Wu 1,2, G Zhang 1,2
PMCID: PMC2364055  PMID: 11461073

Abstract

Hereditary multiple exostoses (EXT) is an autosomal dominant disease characterized by the formation of cartilage-capped prominences (exostoses) that develop from the juxta-epiphyseal regions of the long bones. 3 genes are known to be involved in the formation of exostoses. Among them, EXT1 and EXT2, which encode enzymes that catalyse the biosynthesis of heparan sulfate, an important component of the extracellular matrix, are responsible for over 70% of the EXT cases. A large Chinese family with hereditary multiple exostoses has been analysed and the disease-causing mutation has been found. Blood samples were obtained from 69 family members, including 23 affected individuals. The EXT phenotype was shown to be linked to the EXT2 gene by using 2-point linkage analysis. After polymerase chain reaction (PCR)-single strand conformation polymorphism (SSCP) analysis and DNA sequencing, a previously unreported deletion of a G in exon 3 of EXT2 gene was observed. This deletion co-segregated with the disease phenotype, suggesting that it is the disease-causing mutation in this family. Furthermore, in at least 4 members chondrosarcoma occurred after either an operation or injury of the exostosis and 3 of them died of the malignance in the family. Whether the operation or injury was responsible for the malignant transformation still needs further study. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: hereditary multiple exostoses, EXT2, deletion mutation, chondrosarcoma

Full Text

The Full Text of this article is available as a PDF (198.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahn J., Lüdecke H. J., Lindow S., Horton W. A., Lee B., Wagner M. J., Horsthemke B., Wells D. E. Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXT1). Nat Genet. 1995 Oct;11(2):137–143. doi: 10.1038/ng1095-137. [DOI] [PubMed] [Google Scholar]
  2. Arms D. M., Strecker W. B., Manske P. R., Schoenecker P. L. Management of forearm deformity in multiple hereditary osteochondromatosis. J Pediatr Orthop. 1997 Jul-Aug;17(4):450–454. [PubMed] [Google Scholar]
  3. Hecht J. T., Hogue D., Strong L. C., Hansen M. F., Blanton S. H., Wagner M. Hereditary multiple exostosis and chondrosarcoma: linkage to chromosome II and loss of heterozygosity for EXT-linked markers on chromosomes II and 8. Am J Hum Genet. 1995 May;56(5):1125–1131. [PMC free article] [PubMed] [Google Scholar]
  4. Hennekam R. C. Hereditary multiple exostoses. J Med Genet. 1991 Apr;28(4):262–266. doi: 10.1136/jmg.28.4.262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Lathrop G. M., Lalouel J. M., Julier C., Ott J. Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci U S A. 1984 Jun;81(11):3443–3446. doi: 10.1073/pnas.81.11.3443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Le Merrer M., Legeai-Mallet L., Jeannin P. M., Horsthemke B., Schinzel A., Plauchu H., Toutain A., Achard F., Munnich A., Maroteaux P. A gene for hereditary multiple exostoses maps to chromosome 19p. Hum Mol Genet. 1994 May;3(5):717–722. doi: 10.1093/hmg/3.5.717. [DOI] [PubMed] [Google Scholar]
  7. Lind T., Tufaro F., McCormick C., Lindahl U., Lidholt K. The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate. J Biol Chem. 1998 Oct 9;273(41):26265–26268. doi: 10.1074/jbc.273.41.26265. [DOI] [PubMed] [Google Scholar]
  8. McCormick C., Duncan G., Goutsos K. T., Tufaro F. The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate. Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):668–673. doi: 10.1073/pnas.97.2.668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Miller S. A., Dykes D. D., Polesky H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988 Feb 11;16(3):1215–1215. doi: 10.1093/nar/16.3.1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Porter D. E., Emerton M. E., Villanueva-Lopez F., Simpson A. H. Clinical and radiographic analysis of osteochondromas and growth disturbance in hereditary multiple exostoses. J Pediatr Orthop. 2000 Mar-Apr;20(2):246–250. [PubMed] [Google Scholar]
  11. Raskind W. H., Conrad E. U., Chansky H., Matsushita M. Loss of heterozygosity in chondrosarcomas for markers linked to hereditary multiple exostoses loci on chromosomes 8 and 11. Am J Hum Genet. 1995 May;56(5):1132–1139. [PMC free article] [PubMed] [Google Scholar]
  12. Schmale G. A., Conrad E. U., 3rd, Raskind W. H. The natural history of hereditary multiple exostoses. J Bone Joint Surg Am. 1994 Jul;76(7):986–992. doi: 10.2106/00004623-199407000-00005. [DOI] [PubMed] [Google Scholar]
  13. Stickens D., Clines G., Burbee D., Ramos P., Thomas S., Hogue D., Hecht J. T., Lovett M., Evans G. A. The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genes. Nat Genet. 1996 Sep;14(1):25–32. doi: 10.1038/ng0996-25. [DOI] [PubMed] [Google Scholar]
  14. Sugiura Y., Sugiura I., Iwata H. Hereditary multiple exostosis: diaphyseal aclasis. Jinrui Idengaku Zasshi. 1976 Dec;21(3):149–167. [PubMed] [Google Scholar]
  15. Tang Y., Xia J. H., Zhou J. N., Li H. J., Wang D. P., Dai H. P., Long Z. G., Tang B. S., Huang L., Deng H. X. [Localization of the gene for 4 hereditary multiple exostoses families]. Yi Chuan Xue Bao. 1998;25(1):1–7. [PubMed] [Google Scholar]
  16. Van Hul W., Wuyts W., Hendrickx J., Speleman F., Wauters J., De Boulle K., Van Roy N., Bossuyt P., Willems P. J. Identification of a third EXT-like gene (EXTL3) belonging to the EXT gene family. Genomics. 1998 Jan 15;47(2):230–237. doi: 10.1006/geno.1997.5101. [DOI] [PubMed] [Google Scholar]
  17. Vasseur M. A., Fabre O. Vascular complications of osteochondromas. J Vasc Surg. 2000 Mar;31(3):532–538. [PubMed] [Google Scholar]
  18. Walsh P. S., Metzger D. A., Higuchi R. Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques. 1991 Apr;10(4):506–513. [PubMed] [Google Scholar]
  19. Wicklund C. L., Pauli R. M., Johnston D., Hecht J. T. Natural history study of hereditary multiple exostoses. Am J Med Genet. 1995 Jan 2;55(1):43–46. doi: 10.1002/ajmg.1320550113. [DOI] [PubMed] [Google Scholar]
  20. Wise C. A., Clines G. A., Massa H., Trask B. J., Lovett M. Identification and localization of the gene for EXTL, a third member of the multiple exostoses gene family. Genome Res. 1997 Jan;7(1):10–16. doi: 10.1101/gr.7.1.10. [DOI] [PubMed] [Google Scholar]
  21. Wuyts W., Van Hul W., De Boulle K., Hendrickx J., Bakker E., Vanhoenacker F., Mollica F., Lüdecke H. J., Sayli B. S., Pazzaglia U. E. Mutations in the EXT1 and EXT2 genes in hereditary multiple exostoses. Am J Hum Genet. 1998 Feb;62(2):346–354. doi: 10.1086/301726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Wuyts W., Van Hul W., Hendrickx J., Speleman F., Wauters J., De Boulle K., Van Roy N., Van Agtmael T., Bossuyt P., Willems P. J. Identification and characterization of a novel member of the EXT gene family, EXTL2. Eur J Hum Genet. 1997 Nov-Dec;5(6):382–389. [PubMed] [Google Scholar]
  23. Wuyts W., Van Hul W. Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2 genes. Hum Mutat. 2000;15(3):220–227. doi: 10.1002/(SICI)1098-1004(200003)15:3<220::AID-HUMU2>3.0.CO;2-K. [DOI] [PubMed] [Google Scholar]
  24. Wuyts W., Van Hul W., Wauters J., Nemtsova M., Reyniers E., Van Hul E. V., De Boulle K., de Vries B. B., Hendrickx J., Herrygers I. Positional cloning of a gene involved in hereditary multiple exostoses. Hum Mol Genet. 1996 Oct;5(10):1547–1557. doi: 10.1093/hmg/5.10.1547. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES